Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 33% ± 14% | |
peripheral blood | 16 studies | 37% ± 9% | |
intestine | 10 studies | 33% ± 15% | |
kidney | 8 studies | 33% ± 7% | |
eye | 5 studies | 32% ± 13% | |
bone marrow | 5 studies | 25% ± 7% | |
liver | 5 studies | 33% ± 22% | |
lymph node | 5 studies | 30% ± 6% | |
brain | 5 studies | 26% ± 11% | |
pancreas | 4 studies | 55% ± 12% | |
placenta | 4 studies | 31% ± 16% | |
uterus | 4 studies | 31% ± 14% | |
breast | 4 studies | 26% ± 6% | |
adrenal gland | 3 studies | 28% ± 3% | |
prostate | 3 studies | 32% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3795.15 | 226 / 226 | 100% | 70.53 | 406 / 406 |
stomach | 100% | 4265.21 | 359 / 359 | 100% | 94.49 | 286 / 286 |
esophagus | 100% | 4113.24 | 1444 / 1445 | 100% | 86.24 | 183 / 183 |
intestine | 100% | 5618.53 | 966 / 966 | 100% | 95.72 | 525 / 527 |
breast | 100% | 3607.49 | 459 / 459 | 99% | 74.81 | 1112 / 1118 |
ovary | 99% | 2108.87 | 179 / 180 | 100% | 145.72 | 430 / 430 |
brain | 99% | 3819.93 | 2627 / 2642 | 100% | 71.78 | 705 / 705 |
uterus | 99% | 2334.82 | 169 / 170 | 100% | 82.24 | 458 / 459 |
prostate | 100% | 2514.44 | 244 / 245 | 99% | 66.99 | 499 / 502 |
skin | 100% | 4018.92 | 1806 / 1809 | 99% | 63.13 | 468 / 472 |
bladder | 100% | 3464.24 | 21 / 21 | 99% | 79.19 | 498 / 504 |
pancreas | 99% | 2298.92 | 324 / 328 | 100% | 55.59 | 178 / 178 |
thymus | 99% | 2616.48 | 648 / 653 | 99% | 55.16 | 601 / 605 |
kidney | 100% | 6531.65 | 89 / 89 | 98% | 68.45 | 887 / 901 |
lung | 98% | 2637.24 | 568 / 578 | 100% | 75.85 | 1155 / 1155 |
adrenal gland | 100% | 6864.98 | 258 / 258 | 97% | 76.15 | 224 / 230 |
adipose | 100% | 3748.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 87.57 | 29 / 29 |
muscle | 100% | 15344.69 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3002.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.77 | 1 / 1 |
blood vessel | 99% | 2696.22 | 1325 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 57.02 | 79 / 80 |
heart | 98% | 11050.56 | 840 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 2647.78 | 782 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034551 | Biological process | mitochondrial respiratory chain complex III assembly |
GO_0006122 | Biological process | mitochondrial electron transport, ubiquinol to cytochrome c |
GO_0022904 | Biological process | respiratory electron transport chain |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0005751 | Cellular component | mitochondrial respiratory chain complex IV |
GO_0005750 | Cellular component | mitochondrial respiratory chain complex III |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0008121 | Molecular function | ubiquinol-cytochrome-c reductase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0051537 | Molecular function | 2 iron, 2 sulfur cluster binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | UQCRFS1 |
Protein name | Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)] |
Synonyms | |
Description | FUNCTION: [Cytochrome b-c1 complex subunit Rieske, mitochondrial]: Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation . The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c. The Rieske protein is a catalytic core subunit containing a [2Fe-2S] iron-sulfur cluster. It cycles between 2 conformational states during catalysis to transfer electrons from the quinol bound in the Q(0) site in cytochrome b to cytochrome c1 (By similarity). Incorporation of UQCRFS1 is the penultimate step in complex III assembly . .; FUNCTION: [Cytochrome b-c1 complex subunit 9]: Component of the ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII). UQCRFS1 undergoes proteolytic processing once it is incorporated in the complex III dimer. One of the fragments, called subunit 9, corresponds to its mitochondrial targeting sequence (MTS). The proteolytic processing is necessary for the correct insertion of UQCRFS1 in the complex III dimer, but the persistence of UQCRFS1-derived fragments may prevent newly imported UQCRFS1 to be processed and assembled into complex III and is detrimental for the complex III structure and function. . |
Accessions | ENST00000304863.6 P47985 |